BNP Paribas Financial Markets
OMIC

BNP Paribas Financial Markets’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

BNP Paribas Financial Markets’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34
Closed -$661 – 5663
2024
Q4 		$661 Sell
34
-2
-6% -$37 ﹤0.01% 5137
2024
Q3 		$564 Hold
36
– – ﹤0.01% 3996
2024
Q2 		$304 Buy
+36
New +$421 ﹤0.01% 3919

BNP Paribas Financial Markets's OMIC Position: Q1 2025 in Review

BNP Paribas Financial Markets sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2025, closing a stake of 34 shares — an estimated $661 sold.

BNP Paribas Financial Markets first reported a position in OMIC in Q2 2024 and held it in 3 quarters. The position peaked at $661 in Q4 2024. 0 funds tracked by Wall St. Rank hold OMIC as of Q1 2025.

  • BNP Paribas Financial Markets reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 34 Singular Genomics Systems, Inc. Common Stock shares in Q1 2025, an estimated $661.
  • BNP Paribas Financial Markets first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Singular Genomics Systems, Inc. Common Stock position peaked at $661 in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2025, filed 14 May 2025.